BIOLASE, Inc. (BIOLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 7, 2025, 10:23 AM EST
BIOLASE Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 46.03 | 49.16 | 48.46 | 39.19 | 22.78 | 37.8 |
Revenue Growth | -7.44% | 1.45% | 23.66% | 72.03% | -39.73% | -18.10% |
Gross Profit Gross Profit Growth | 15.85 | 16.72 | 15.91 | 15.83 | 6.17 | 14.29 |
Operating Income Operating Income Growth | -12.72 | -17.14 | -25.34 | -17.42 | -18.54 | -15.62 |
Net Income Net Income Growth | -15.97 | -37.62 | -28.85 | -16.7 | -34.21 | -17.86 |
Earnings Per Share EPS Growth | -0.71 | -29.44 | -418.13 | -283.12 | -1399.06 | - |
EPS Growth | - | - | - | - | - | - |
Revenue by Geography
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
United States United States Growth | 32.26 | 33.88 | 33.88 | 25.38 | 16.2 | 22.81 |
International International Growth | 13.76 | 15.28 | 14.59 | 13.8 | 6.59 | 14.99 |
Total Total Growth | 46.03 | 49.16 | 48.46 | 39.19 | 22.78 | 37.8 |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 3.44 | 6.57 | 4.18 | 29.97 | 17.56 | 5.79 |
Total Debt Total Debt Growth | 17.11 | 15.71 | 15.69 | 15.46 | 18.27 | 13.79 |
Net Cash (Debt) Net Cash Growth | -13.67 | -9.14 | -11.51 | 14.52 | -0.7 | -8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.60 | -7.15 | -166.77 | 246.02 | -28.67 | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -13.43 | -14.09 | -26.76 | -16.71 | -12.8 | -12.75 |
Capital Expenditures CapEx Growth | -0.25 | -1.31 | -3.73 | -0.71 | -0.1 | -0.21 |
Free Cash Flow Free Cash Flow Growth | -13.68 | -15.4 | -30.49 | -17.42 | -12.89 | -12.95 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 34.44% | 34.02% | 32.83% | 40.39% | 27.10% | 37.80% |
Operating Margin | -27.63% | -34.86% | -52.28% | -44.44% | -81.37% | -41.33% |
Pretax Margin | -34.77% | -41.90% | -58.86% | -41.07% | -73.31% | -47.35% |
Profit Margin | -34.69% | -76.52% | -59.53% | -42.63% | -150.16% | -47.24% |
FCF Margin | -29.72% | -31.33% | -62.91% | -44.45% | -56.59% | -34.27% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Forward PE | - | 90.33 | 90.33 | 90.33 | 90.33 | 90.33 |
PS Ratio | 0 | 0.08 | 0.10 | 1.53 | 1.71 | 0.45 |